Skip to main content

CrisprBits

CrisprBits

Type

startup

Founded

2020

Funding captured

$3.0m

Deals captured

1

About CrisprBits

CrisprBits is a biotechnology startup focused on developing CRISPR-based molecular diagnostics. The company builds diagnostic platforms and assays that leverage CRISPR gene-editing biology to detect pathogens and molecular signatures rapidly and with high sensitivity. Its offerings target clinical and point-of-care laboratories, aiming to commercialise scalable, manufacturable tests for infectious and other high-impact diseases, and to expand access to advanced molecular diagnostics in emerging markets.

CrisprBits funding captured (1)

Deal typeStageDateAmountInvestors
EquityPre-SeedNov 25, 2025$3.0m